Literature DB >> 18538503

Bowel, urinary, and sexual problems among long-term prostate cancer survivors: a population-based study.

Floortje Mols1, Ida J Korfage, Ad J J M Vingerhoets, Paul J M Kil, Jan Willem W Coebergh, Marie-Louise Essink-Bot, Lonneke V van de Poll-Franse.   

Abstract

PURPOSE: To obtain insight into the long-term (5- to 10-year) effects of prostate cancer and treatment on bowel, urinary, and sexual function, we performed a population-based study. Prostate-specific function was compared with an age-matched normative population without prostate cancer. METHODS AND MATERIALS: Through the population-based Eindhoven Cancer Registry, we selected all men diagnosed with prostate cancer between 1994 and 1998 in the southern Netherlands. In total, 964 patients, alive in November 2004, received questionnaire; 780 (81%) responded.
RESULTS: Urinary problems were most common after a prostatectomy; bowel problems were most common after radiotherapy. Compared with an age-matched normative population both urinary and bowel functioning and bother were significantly worse among survivors. Urinary incontinence was reported by 23-48% of survivors compared with 4% of the normative population. Bowel leakage occurred in 5-14% of patients compared with 2% of norms. Erection problems occurred in 40-74% of patients compared with 18% of norms.
CONCLUSIONS: These results form an important contribution to the limited information available on prostate-specific problems in the growing group of long-term prostate cancer survivors. Bowel, urinary, and sexual problems occur more often among long-term survivors compared with a reference group and cannot be explained merely by age. Because these problems persist for many years, urologists should provide patients with adequate information before treatment. After treatment, there should be an appropriate focus on these problems.

Entities:  

Mesh:

Year:  2008        PMID: 18538503     DOI: 10.1016/j.ijrobp.2008.04.004

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  18 in total

Review 1.  Psychological Impacts of Male Sexual Dysfunction in Pelvic Cancer Survivorship.

Authors:  David K Twitchell; Daniela A Wittmann; James M Hotaling; Alexander W Pastuszak
Journal:  Sex Med Rev       Date:  2019-03-26

2.  Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trial.

Authors:  Kathryn L Taylor; George Luta; Anthony B Miller; Timothy R Church; Scott P Kelly; Larry R Muenz; Kimberly M Davis; David L Dawson; Sara Edmond; Douglas Reding; Jerome E Mabie; Thomas L Riley
Journal:  J Clin Oncol       Date:  2012-06-25       Impact factor: 44.544

3.  Quality-of-life effects of prostate-specific antigen screening.

Authors:  Eveline A M Heijnsdijk; Elisabeth M Wever; Anssi Auvinen; Jonas Hugosson; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Arnauld Villers; Alvaro Páez; Sue M Moss; Marco Zappa; Teuvo L J Tammela; Tuukka Mäkinen; Sigrid Carlsson; Ida J Korfage; Marie-Louise Essink-Bot; Suzie J Otto; Gerrit Draisma; Chris H Bangma; Monique J Roobol; Fritz H Schröder; Harry J de Koning
Journal:  N Engl J Med       Date:  2012-08-16       Impact factor: 91.245

4.  Cost-effectiveness of MR Imaging-guided Strategies for Detection of Prostate Cancer in Biopsy-Naive Men.

Authors:  Shivani Pahwa; Nicholas K Schiltz; Lee E Ponsky; Ziang Lu; Mark A Griswold; Vikas Gulani
Journal:  Radiology       Date:  2017-05-17       Impact factor: 11.105

5.  Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells.

Authors:  Thippeswamy Gulappa; Ramadevi Subramani Reddy; Suman Suman; Alice M Nyakeriga; Chendil Damodaran
Journal:  Cancer Lett       Date:  2013-05-16       Impact factor: 8.679

6.  Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.

Authors:  Kathryn L Taylor; Richard M Hoffman; Kimberly M Davis; George Luta; Amethyst Leimpeter; Tania Lobo; Scott P Kelly; Jun Shan; David Aaronson; Catherine A Tomko; Amy J Starosta; Charlotte J Hagerman; Stephen K Van Den Eeden
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-06-02       Impact factor: 4.254

7.  Anxiety and Depression in Cancer Patients: The Association with Religiosity and Religious Coping.

Authors:  Guan Chong Ng; Salina Mohamed; Ahmad Hatim Sulaiman; Nor Zuraida Zainal
Journal:  J Relig Health       Date:  2017-04

8.  Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer.

Authors:  M T King; R Viney; D P Smith; I Hossain; D Street; E Savage; S Fowler; M P Berry; M Stockler; P Cozzi; P Stricker; J Ward; B K Armstrong
Journal:  Br J Cancer       Date:  2012-01-24       Impact factor: 7.640

9.  Urinary and sexual outcomes in long-term (5+ years) prostate cancer disease free survivors after radical prostatectomy.

Authors:  Mauro Gacci; Alchiede Simonato; Lorenzo Masieri; John L Gore; Michele Lanciotti; Annalisa Mantella; Mario Alberto Rossetti; Sergio Serni; Virginia Varca; Andrea Romagnoli; Carlo Ambruosi; Fabio Venzano; Marco Esposito; Tomaso Montanaro; Giorgio Carmignani; Marco Carini
Journal:  Health Qual Life Outcomes       Date:  2009-11-13       Impact factor: 3.186

10.  Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer.

Authors:  E A M Heijnsdijk; A der Kinderen; E M Wever; G Draisma; M J Roobol; H J de Koning
Journal:  Br J Cancer       Date:  2009-11-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.